{"tm":1686889300,"s":"CRSP","news":[{"t":"10 DNA Stocks Billionaires Are Loading Up On","dt":"Jun-14-23 11:40AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/10-dna-stocks-billionaires-loading-154054254.html"},{"t":"This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?","dt":"05:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/913276b7-13c8-30ea-9301-25ed5e96e433\/this-move-is-a-first-for-the.html"},{"t":"FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel","dt":"01:37PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/fda-accepts-vertex-vrtx-crisprs-173700825.html"},{"t":"Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress","dt":"03:01AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/positive-results-pivotal-trials-exa-070100851.html"},{"t":"Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?","dt":"06:00AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/ed836381-d487-3a9a-a164-b8a55ed92c87\/could-crispr-therapeutics.html"},{"t":"CRISPR Therapeutics: A Galaxy's Worth of Deep Value","dt":"May-31-23 07:45AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/fac8b3e8-01c1-3b6d-ad68-8d60fce00a1d\/crispr-therapeutics%3A-a.html"},{"t":"Prediction: These 2 Stocks Could Double In the Next Year","dt":"May-28-23 10:15AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/59f365c7-e875-36a0-a005-31a132ebcbf6\/prediction%3A-these-2-stocks.html"},{"t":"2 Top Trends to Invest $5,000 in Right Now","dt":"May-25-23 09:40AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/0565c9b3-4b1b-3c42-819c-903d6c955297\/2-top-trends-to-invest-%245%2C000.html"},{"t":"Cathie Wood Just Sold CRISPR Therapeutics Stock. Here's Why You Should Consider Buying It","dt":"May-21-23 09:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/bda56125-ce84-3776-8a43-7989354bdc54\/cathie-wood-just-sold-crispr.html"},{"t":"Why Are CRISPR Therapeutics Charts Saying 'Buy'?","dt":"May-15-23 01:00PM","a":"TheStreet.com","u":"https:\/\/finance.yahoo.com\/m\/55f43173-68bc-37f7-b499-1da9c8d3921d\/why-are-crispr-therapeutics.html"},{"t":"CRISPR Therapeutics Stock Sees Relative Strength Rating Rise To 89","dt":"May-10-23 10:53AM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/cd669314-4820-3175-aca0-7bde66348b86\/crispr-therapeutics-stock.html"},{"t":"Why CRISPR Therapeutics Stock Is on Fire Today","dt":"02:25PM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/d764dc95-e1d5-32fc-af2e-3e29bed7f34e\/why-crispr-therapeutics-stock.html"},{"t":"CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results","dt":"04:01PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/crispr-therapeutics-provides-business-reports-200100628.html"},{"t":"CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?","dt":"May-02-23 12:49PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/crispr-crsp-report-q1-earnings-164904976.html"},{"t":"Why the human genome could be health cares holy grail","dt":"May-01-23 08:20PM","a":"Yahoo Finance Video","u":"https:\/\/finance.yahoo.com\/video\/why-human-genome-could-healthcare-002054101.html"},{"t":"12 Gene Editing Stocks With the Best Long-Term Potential","dt":"Apr-26-23 02:10PM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/12-gene-editing-stocks-best-181003764.html"},{"t":"CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know","dt":"Apr-24-23 06:00PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/crispr-therapeutics-ag-crsp-stock-220010077.html"},{"t":"3 Stocks With Huge Catalysts on the Way","dt":"Apr-22-23 06:18AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/cddf31df-5d7c-35b1-8f8b-0343629e1c2e\/3-stocks-with-huge-catalysts.html"},{"t":"2 Growth Stocks That Could Keep Growing for Decades","dt":"07:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/9556bc16-0ef6-389e-8a88-d7759d09c82e\/2-growth-stocks-that-could.html"},{"t":"3 High-Growth Biotech Stocks Poised for Success in 2023","dt":"Apr-18-23 06:40AM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-high-growth-biotech-stocks-104045550.html"},{"t":"Why Shares of Editas Medicine Rose Monday","dt":"02:50PM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/ab1e67ee-b350-3e1a-8d5b-d67c70060aa3\/why-shares-of-editas-medicine.html"},{"t":"Regulus (RGLS) Surges on Enrollment Completion for RGLS8429","dt":"12:49PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regulus-rgls-surges-enrollment-completion-164904166.html"},{"t":"CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?","dt":"03:13AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/crispr-therapeutics-ag-crsp-soars-071307912.html"},{"t":"Why Shares of CRISPR Therapeutics Jumped Thursday","dt":"11:58AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/b17e4710-8d14-3557-8806-c035aa8d3348\/why-shares-of-crispr.html"},{"t":"UPDATE 1-Vertex\/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group","dt":"Apr-12-23 06:10PM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/1-vertex-crisprs-gene-editing-221058308.html"},{"t":"Could This Move Make Vertex's Next Blockbuster Even Bigger?","dt":"05:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/3f4d95b3-4587-352c-9f9f-def4f72392a6\/could-this-move-make-vertex%27s.html"},{"t":"MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study","dt":"Apr-06-23 12:19PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/morphosys-finishing-early-enrolment-myelofibrosis-161904521.html"},{"t":"AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal","dt":"Apr-05-23 12:25PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/astrazenecas-azn-drug-combo-meets-162504788.html"},{"t":"Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?","dt":"Apr-04-23 02:00PM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/cd161530-68ba-3535-a336-2aaaf5775b79\/vertex-is-1-step-closer-to.html"},{"t":"CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know","dt":"Apr-03-23 06:15PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/crispr-therapeutics-ag-crsp-gains-221510682.html"},{"t":"Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics","dt":"Apr-01-23 05:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/aa88a08e-8ec6-3811-8c3b-a5af3596a3c1\/here%27s-a-new-million-dollar.html"},{"t":"2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It","dt":"Mar-30-23 08:45AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/09493797-03b3-3950-b782-8d0457c304a2\/2-reasons-to-sell-editas.html"},{"t":"12 Most Promising Healthcare Stocks According to Analysts","dt":"04:40PM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/12-most-promising-healthcare-stocks-204054903.html"}]}